Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11503338rdf:typepubmed:Citationlld:pubmed
pubmed-article:11503338lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:11503338lifeskim:mentionsumls-concept:C0031154lld:lifeskim
pubmed-article:11503338lifeskim:mentionsumls-concept:C0205219lld:lifeskim
pubmed-article:11503338lifeskim:mentionsumls-concept:C1521827lld:lifeskim
pubmed-article:11503338lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:11503338lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:11503338pubmed:issue5lld:pubmed
pubmed-article:11503338pubmed:dateCreated2001-8-15lld:pubmed
pubmed-article:11503338pubmed:abstractTextThe proteins proteolysis increase as well as their biosynthesis disorder were observed in experimental diffuse purulent peritonitis, which was simulated in rats of Wistar line. Application of baxtims preparation for the abdominal cavity treatment during 14 days had promoted restoration of this process and the proteinic deficiency elimination as well.lld:pubmed
pubmed-article:11503338pubmed:languageruslld:pubmed
pubmed-article:11503338pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11503338pubmed:citationSubsetIMlld:pubmed
pubmed-article:11503338pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11503338pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11503338pubmed:statusMEDLINElld:pubmed
pubmed-article:11503338pubmed:issn0023-2130lld:pubmed
pubmed-article:11503338pubmed:authorpubmed-author:KasymovA...lld:pubmed
pubmed-article:11503338pubmed:authorpubmed-author:BazhenovL GLGlld:pubmed
pubmed-article:11503338pubmed:authorpubmed-author:GutnikovaA...lld:pubmed
pubmed-article:11503338pubmed:authorpubmed-author:SaidkhanovV...lld:pubmed
pubmed-article:11503338pubmed:authorpubmed-author:MakhmudovK...lld:pubmed
pubmed-article:11503338pubmed:issnTypePrintlld:pubmed
pubmed-article:11503338pubmed:ownerNLMlld:pubmed
pubmed-article:11503338pubmed:authorsCompleteYlld:pubmed
pubmed-article:11503338pubmed:pagination49-51lld:pubmed
pubmed-article:11503338pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:meshHeadingpubmed-meshheading:11503338...lld:pubmed
pubmed-article:11503338pubmed:year2001lld:pubmed
pubmed-article:11503338pubmed:articleTitle[Application of baxtims preparation in treatment of experimental diffuse purulent peritonitis].lld:pubmed
pubmed-article:11503338pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11503338pubmed:publicationTypeEnglish Abstractlld:pubmed